Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Journals Home

SIGN IN

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Narrow View

NARROW

Content Type

Meeting Abstract (9)
Journal Articles (3)

Journal

Investigative Ophthalmology & Visual Science (12)

Article Type

ARVO Annual Meeting Abstract (9)
Glaucoma (1)
Nantotechnology and Regenerative Medicine (1)
Retinal Cell Biology (1)

Topics

Eye Anatomy and Disorders (2)
Pharmacology (2)
Biochemistry and Molecular Biology (1)
Genetics (1)
Glaucoma (1)
Nanotechnology and Regenerative Medicine (1)
Retina (1)
Retinal Cell Biology (1)
Visual Neuroscience (1)

Tags

retinal ganglion cells (2)
axon (1)
bevacizumab (1)
choroidal neovascularization (1)
cicatrix (1)
cornea (1)
cpps trial (1)
eye (1)
eyedrops (1)
fibrosis (1)

Specify Date Range

From: To: Apply

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Membrane Penetrating Poly Amines as Non-Invasive Drug Delivery Vehicles for anti-VEGF Therapies to Treat Neovascular Age-Related Macular Degeneration

Naa Dei Nikoi; Thomas Lovatt; Anna F.A. Peacock; Felicity de Cogan

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2904. doi:

ARVO Annual Meeting Abstract July 2018

Topical treatment for AMD: Non-invasive delivery and efficacy of ranibizumab and bevacizumab in rabbit and porcine eyes

Felicity De Cogan; Aisling Lynch; Matthew Berwick; Anna Peacock; Samer Elsherbiny; Heping Xu; Mei Chen

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1439. doi:

Nantotechnology and Regenerative Medicine May 2017

Topical Delivery of Anti-VEGF Drugs to the Ocular Posterior Segment Using Cell-Penetrating Peptides

PDF

Felicity de Cogan; Lisa J. Hill; Aisling Lynch; Peter J. Morgan-Warren; Judith Lechner; Matthew R. Berwick; Anna F. A. Peacock; Mei Chen; Robert A. H. Scott; Heping Xu; Ann Logan
TAGS: eye, eyedrops, peptides, retina, cpps trial, cornea, bevacizumab, choroidal neovascularization, mice
Invest. Ophthalmol. Vis. Sci.. 2017; 58(5):2578-2590. doi: https://doi.org/10.1167/iovs.16-20072

ARVO Annual Meeting Abstract September 2016

Development of a hydrogel flowable dressing for the prevention of corneal scarring

Gurpreet Chouhan; Felicity De Cogan; Lisa J Hill; Saaeha Rauz; Ann Logan; Liam M. Grover

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):288. doi:

ARVO Annual Meeting Abstract September 2016

Cell-penetrating peptides as non-invasive drug delivery vehicles for ranibizumab and bevacizumab.

Felicity de Cogan; Lisa J Hill; Peter Morgan-Warren; Mei Chen; Robert Scott; Heping Xu; Ann Logan

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4037. doi:

ARVO Annual Meeting Abstract September 2016

RhoA-mediated contractility of the trabecular meshwork regulates intraocular pressure in the early but not in the late fibrotic phase of Primary Open Angle Glaucoma

Lisa J Hill; Ben Mead; Felicity de Cogan; Elena Feinstein; Zubair Ahmed; Richard J Blanch; Peter Morgan-Warren; Martin Berry; Ann Logan

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4690. doi:

Retinal Cell Biology February 2016

siRNA-Mediated Knockdown of the mTOR Inhibitor RTP801 Promotes Retinal Ganglion Cell Survival and Axon Elongation by Direct and Indirect Mechanisms

PDF

Peter J. Morgan-Warren; Jenna O'Neill; Felicity de Cogan; Igor Spivak; Hagit Ashush; Hagar Kalinski; Zubair Ahmed; Martin Berry; Elena Feinstein; Robert A. H. Scott; Ann Logan
TAGS: axon, mtor inhibitors, neurites, neuroglia, retinal ganglion cells, rna, small interfering, wounds and injuries, nerve growth factors, intravitreal injections, glial fibrillary acidic protein
Invest. Ophthalmol. Vis. Sci.. 2016; 57(2):429-443. doi: https://doi.org/10.1167/iovs.15-17511

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

Cell-penetrating peptide constructs as non-invasive drug delivery vehicles for ranibizumab and bevacizumab.

Felicity De Cogan; Peter Morgan-Warren; Lisa J Hill; Robert A H Scott; Ann Logan

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4147. doi:

Glaucoma June 2015

Decorin Reduces Intraocular Pressure and Retinal Ganglion Cell Loss in Rodents Through Fibrolysis of the Scarred Trabecular Meshwork

PDF

Lisa J. Hill; Ben Mead; Richard J. Blanch; Zubair Ahmed; Felicity De Cogan; Peter J. Morgan-Warren; Shabbir Mohamed; Wendy Leadbeater; Robert A. H. Scott; Martin Berry; Ann Logan
TAGS: fibrosis, intraocular pressure, rodentia, trabecular meshwork, cicatrix, injections, retinal ganglion cells, immunohistochemistry
Invest. Ophthalmol. Vis. Sci.. 2015; 56(6):3743-3757. doi: https://doi.org/10.1167/iovs.14-15622

ARVO Annual Meeting Abstract June 2015

Decorin, a vitreal proteoglycan, is diminished in patients who develop Proliferative Vitreoretinopathy Retinopathy following retinal detachment

Lisa J Hill; Felicity De Cogan; Richard J Blanch; Robert A H Scott; Ann Logan

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):212. doi:

ARVO Annual Meeting Abstract June 2015

Development of a synthetic anti-scarring dressing for the prevention of corneal scarring

Gurpreet Chouhan; Ann Logan; Saaeha Rauz; Robert A H Scott; Felicity De Cogan; Liam M. Grover

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2471. doi:

ARVO Annual Meeting Abstract April 2014

The role of Decorin in ocular ageing and disease

Felicity de Cogan; Jenna ONeill; Richard J Blanch; Robert A H Scott; Ann Logan

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):400. doi:

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept